To determine the relationship between levels of Mycobacterium avium complex (MAC) in blood and tissues, histopathologic examination and quantitative MAC cultures were done on blood samples and tissue samples of 7 organs at autopsy of 10 AIDS patients who had been treated for MAC bacteremia. Blood and tissue cultures were negative for MAC for 3 of the patients and positive for 7. The numbers of MAC colony-forming units in the blood and tissues were highly correlated. The highest concentrations of MAC were observed in the reticuloendothelial organs, with a maximum of 6.9 10glO cfu/g in mesenteric lymph nodes and 6.8 loglo cfu/g in spleen. Histopathologic findings paralleled quantitative cultures and were consistent with entry of MAC via lymphatics through the gastrointestinal tract, followed by hematogenous dissemination.
To determine the relationship between levels of Mycobacterium avium complex (MAC) in blood and tissues, histopathologic examination and quantitative MAC cultures were done on blood samples and tissue samples of 7 organs at autopsy of 10 AIDS patients who had been treated for MAC bacteremia. Blood and tissue cultures were negative for MAC for 3 of the patients and positive for 7. The numbers of MAC colony-forming units in the blood and tissues were highly correlated. The highest concentrations of MAC were observed in the reticuloendothelial organs, with a maximum of 6.9 10glO cfu/g in mesenteric lymph nodes and 6.8 loglo cfu/g in spleen. Histopathologic findings paralleled quantitative cultures and were consistent with entry of MAC via lymphatics through the gastrointestinal tract, followed by hematogenous dissemination.
The quantitation of Mycobacterium avium complex (MAC) in blood is utilized in clinical trials to evaluate the efficacy of therapeutic agents for the treatment of MAC bacteremia in AIDS patients [1] [2] [3] [4] [5] . However, the relationship between levels of mycobacteremia and the burden of organisms in tissues is not known. Early studies of the microbiologic and pathologic findings in disseminated MAC in AIDS reported that tissues were uniformly laden with epithelioid granulomas containing foamy histiocytes (FH) with MAC at levels up to 10 10 cfuJg of tissue [6] . The prevailing pathogenic model for such studies was that MAC bacteremia represented a spillover from heavily infected organs [6] [7] [8] [9] [10] . Subsequently, tissue burden has been found to be much more variable, suggesting a different pathogenesis [11] . After colonization, low levels of MAC bacteremia may be only transiently detectable yet lead to widespread seeding of tissues [12] . In untreated patients, higher levels of mycobacteria produce symptoms and extensive tissue involvement [11] [12] [13] [14] . Consistent with this concept, tissue burden appears to depend on length of survival after diagnosis [11] . This prospective study characterizes the relationship between circulating levels of MAC, MAC tissue burden, and the spectrum of histopathology present at autopsy in patients treated for MAC bacteremia.
Materials and Methods
Study population. Study subjects were human immunodeficiency virus (HIV)-infected persons (~18 years old) who had been diagnosed with MAC bacteremia before dying. All subjects underwent complete autopsy at the University of California, San Diego, Medical Center between 18 October 1993 and 6 November 1994. Four subjects had been participants in an open-label randomized clinical trial comparing clarithromycin and clofazimine with clarithromycin, clofazimine, and ethambutol for the treatment of MAC bacteremia.
Clinical evaluation. Information regarding clinical signs and symptoms and laboratory values present at the first blood culture positive for MAC was obtained by chart review. Clinical disease at baseline (date of first blood culture positive for MAC) was defined as two or more of the following signs: fever (temperaturẽ 38°C), night sweats, anemia (hemoglobin ::;;8.5 g/dL), elevated alkaline phosphatase (~260 lUlL), and weight loss (~IO% of body weight since onset of symptoms).
Results of all blood cultures for MAC prior to death were obtained from laboratory records. The 4 participants in the clinical trial had monthly quantitative MAC blood cultures done using a lysis centrifugation system (Isolator-lO; Wampole Laboratories, Cranbury, NJ) [4] .
Microbiology. Blood and tissue specimens were collected at autopsy, 4-24 h after death. Blood (10 mL) drawn from the right ventricle was used for quantitative culture in the lysis centrifugation system [4] . The theoretical limit of detection of this method is 0.1 cfu/mL [4] . At 12 weeks, cultures without growth were considered sterile. About 2 g oftissue for quantitative cultures was randomly harvested from spleen, liver, mesenteric lymph nodes, vertebral bone marrow, ileum, colon, lung, and myocardium. After decontamination with N-acetyl-L-cysteine-sodium hydroxide [15] , tissues were diluted with 4 mL of sterile broth and mechanically emulsified with a stomacher for 2 min. Supernatant was collected, diluted, and plated onto 7H1O agar medium as follows: five direct plates (no dilution) and two plates each at 1: 10, 1: 100, and 1: 1000. The plates were incubated for 12 weeks at 37°C in 5% CO 2 , and the number of colony-forming units (cfu) per milliliter of blood or gram of tissue was determined as previously described [4, 6] . . Six of7 culture-positive and 1 of3 culture-negative patients were on prophylaxis with rifabutin when diagnosed with MAC bacteremia. All were treated with a regimen containing clarithromycin and at least one other antimycobacterial agent (ethambutol, clofazimine, ciprofloxacin, rifabutin, or amikacin) for a median of 4.2 months (range, 0.8-25.5). For 6 patients, treatment was prescribed up until the time of death. In the remaining 4 patients, treatment was discontinued 6.8, 2.6, 1.7, and 0.7 months before death.
Microbiology. All 7 patients with mycobacteria in tissues at autopsy also had positive blood cultures. Nucleic acid probes of pooled tissue and blood isolates from each patient revealed M. avium; none was positive for M. tuberculosis. All cultures All organisms isolated from tissue and blood were probed with species-specific nucleic acid probes for M. avium and Mycobacterium tuberculosis for identification (AccuProbe; Gen-Probe, San Diego).
Pathology. Sections were taken from all sites sampled for quantitative cultures and stained with hematoxylin-eosin and Fite tissue stain for acid-fast bacilli (AFB). Vertebral bone marrow was first decalcified for 24-48 h with 14% hydrochloric acid (TBD-1; Shandon, Pittsburgh) and then stained with hematoxylin-eosin and Fite tissue stain.
The organs were assessed by a pathologist (C.A.B.) using a semiquantitative scale for the presence of FH, AFB, and granulomas (table 1) .
Data analysis. Data were analyzed using statistical software (BMDP, Los Angeles). Continuous variables were compared by parametric and nonparametric tests, and Fisher's exact test was used to compare categorical data. Quantitative culture results were 10glO transformed; negative cultures were assigned the value 0.1 cfu/mL or g (log 0.1 = -1), corresponding to the limit of detection.
The sensitivity and specificity of detecting cultured MAC by AFB staining of histologic specimens were determined for 60 specimens; bone marrow and lung were excluded. Spearman's nonparametric rank correlation between the mean 10gIO cfu in the blood and tissue was calculated. In addition, mean 10glO cfu in blood and reticuloendothelial organs (lymph nodes, spleen, liver, bone marrow), as well as in blood and gastrointestinal organs (ileum, colon) were compared using Spearman's method. The means of log cfu in individual organs, grouped by histology (presence or absence of AFB or FH), were compared by use of the MannWhitney rank sum t test.
Results
Clinicalfindings. Between 18 October 1993 and 6 November 1994, complete autopsies were done at a median of 22 h after death (range, 4-48 h) on 10 HIV-positive men. Demographic data and baseline clinical and laboratory findings are shown in table 2. By the 1987 Centers for Disease Control and Prevention AIDS-defining criteria, MAC was the AIDSdefining diagnosis for 3 patients. According to the criteria defined in Materials and Methods, 7 patients were symptomatic at the time of MAC diagnosis, none were anemic, and 3 had elevated levels of alkaline phosphatase. The median CD4 cell count was 7 cells/mm 3 (range, 1-82). for the 3 remaining patients failed to grow MAC. Blood culture results at autopsy and before death are shown in table 3. Four patients had monthly sequential quantitative MAC blood cultures drawn before death. Four months before autopsy, patient 3, who had been treated with clarithromycin, ethambutol, and clofazimine, had a level of MAC bacteremia of 8 cfu/ mL, while all four subsequent monthly cultures were sterile. In patient 5, the level of MAC bacteremia before treatment and 6.5 months before death was 44 cfu/mL; it decreased to 0.2 cfu/mL while the patient was on treatment but returned to 44 cfulmL 1.6 months after treatment was stopped (1 month before autopsy). Patient 8, who had low-level bacteremia (4 cfu/mL) before treatment (9.6 months before death), had blood sterilized by a regimen of clarithromycin and clofazimine but relapsed 5 months later with an organism resistant to clarithromycin. MAC blood counts increased progressively to 7 cfu/mL before treatment was stopped (1.5 months before autopsy). At diagnosis, patient 10 had high-level MAC bacteremia (504 cfu/mL), which slowly decreased during treatment to 36 cfu/mL (2 months prior to death).
In our small sample ofpatients, neither length nor persistence oftreatment until death appeared to affect the load of organisms measured in the blood and tissues (table 3) . The highest concentration of MAC cultured in the lymph nodes was in a patient who had had MAC for 25.7 months and who had been treated for 12.7 months, up to 0.7 months before death. Two of 3 patients with sterile cultures (patients 3 and 9) had been treated within days of death, but the third (no. 4) had been without treatment for almost 7 months. Moreover, the patient with the highest postmortem counts (no. 7) had been treated up until 20 days before death.
Of the 7 patients with MAC in both blood and tissues, all but 1 (no. 6) had positive blood cultures 0.3-3 months before death. In patient 6, 2 blood cultures, obtained for clinical management and cultured in the BACTEC l3A system [16] ,were negative after 4 weeks.
Ofthe 3 patients with sterile blood and tissue cultures, patient 3 had 4 sterile cultures 1.8 months before death and patients 4 and 9 had positive cultures 10.8 and 25.5 months, respectively, before death.
In the 7 patients with positive cultures, there was a wide range in the concentration ofmycobacteria cultured from blood (median, 1.7 10gIO cfu/mL; range, 1.5-3.9) and from tissues (table 4). The highest median concentrations of MAC were found in the mesenteric lymph nodes (4.610g lO cfu/g), followed by the spleen (4.4 10gIO cfu/g), colon (2.9 10gIO cfu/g), lung (2.9 10gIO cfu/g), bone marrow (2.3 10gIO cfu/g), ileum (2.2 10gIO cfu/g), and liver (2.1 10gIO cfu/g). In the myocardium, a tissue rarely involved by MAC, the median concentration was lower than that in blood (1.1 10gIO cfu/g).
Numbers figure 1 .
Overall, counts of mycobacteria in blood were highly correlated with combined counts in the reticuloendothelial organs and in the gastrointestinal organs (r s , .88; P = .002).
Pathology. Gross examination revealed that in patients with positive blood cultures, mesenteric lymph nodes and spleen most often displayed abnormalities characteristic of MAC in AIDS patients. Lymph nodes were firm, up to 3 cm long, and tan upon sectioning. Yellow or white nodules measuring a few millimeters were visible and palpable throughout the spleen. Only 1 patient had liver and bowel involvement, seen as yellow nodules throughout the liver and under an intact mucosa in the ileum. Bone marrow, lung, and myocardium had no macroscopic lesions compatible with MAC infection. Microscopic examination. With rare exception, FH were the predominant pathologic feature in MAC-infected organs. Numbers of AFB varied considerably among patients: They were visible in the lymph nodes and liver of 8 of 10 patients, spleen of 7, ileum of 6, and colon of 4. Only I patient had AFB in the bone marrow, and no patient had visible AFB in the myocardium and lung.
The pattern of the histiocytes in infected tissues ranged from a few scattered cells, identifiable only retrospectively after staining for AFB, to complete replacement ofthe normal parenchyma. Variation between organs in a given patient was also striking. The most prominent collections of FH were in the reticuloendothelial organs. In the lymph nodes, confluent collections of FH completely replaced the normal architecture in 7 of 10 patients. One of the 3 remaining patients had 50% replacement by FH; 2 others had nodes markedly depleted of lymphocytes but with only small collections of FH. The subcapsular sinuses, where the afferent lymphatic vessels empty [17] , had no FH. In the spleen, periarteriolar FH collections ranged from rare single cells to near replacement of the parenchyma ( figure 2A, B) . In the liver, portal or parenchymal macrophage aggregates were observed in most patients, and 4 patients had poorly formed granulomas in either the portal tracts or in the parenchyma. The poorly formed granulomas consisted of a small collection of histiocytes surrounded by a rim of lymphocytes. All but 1 patient had parenchymal Kupffer cell aggregates, which ranged from a tiny collection of a few cells to very large aggregates, which in one case spanned lobules. In the vertebral bone marrow, a few small collections of FH were present in only 2 patients. Involvement of the gastrointestinal tract by FH was focal. In the small intestine, club-shaped villi were distended by collections of FH in 5 patients. Collections of FH deeper in the lamina propria of the small intestine were also present in some patients ( figure 2C, D) . Most patients had one or two small collections ofFH in the lamina propria ofthe colon. One patient had small submucosal collections associated with numerous acid-fast organisms, while another patient had diffuse involvement of the lamina propria by FH, but only one poorly formed granuloma was observed. FH were not seen in the myocardium, bone marrow, or lung.
Two of 3 patients with negative blood and tissue cultures had histologically involved organs: Patient 4 had rare FH, of which 10%-50% containedAFB in a mesenteric lymph node; patient 9 had rare AFB in his liver and ileum.
In patients with positive blood and tissue cultures, discordance between FH and AFB was seen only in the gastrointestinal system (patient 5 had no FH and one AFB in colon and ileum samples; patients 6 and 7 had very few FH and no AFB in colon samples).
Of 60 specimens, 29 had both visible and culturable AFB. AFB were neither seen nor cultured in 15 specimens. Four specimens were AFB positive but culture negative, and in 12 specimens, AFB were not seen, but cultures grew MAC. Thus, the sensitivity of detecting culturable MAC using visualized AFB at histopathology was 71 % and specificity was 79%.
Semiquantitative histologic assessment of AFB and FH were highly concordant (r = .93, P < .001). MAC cfu from quantitative tissue cultures were significantly higher in patients with FH or AFB detected in the spleen (FH, P = .001; AFB, P = .01) or with AFB in the liver (P = .01) or ileum (P = .008).
For tissues reaching a 3-4 histologic scale of involvement, mycobacteria concentrations tended to be at least 3 10gIO cfu/ g of tissue. When MAC colony counts were averaged in the reticuloendothelial system, there was a mean of 4.6 10gIO cfu/ g for patients with positive histology, compared with -1 10gIO cfu/g for patients with negative findings (P = .06).
Discussion
Our observations that tissue burden is highly correlated to the level of MAC bacteremia and that organ involvement is detectable only in the presence of MAC bacteremia refines a recently proposed model of the pathogenesis of disseminated MAC [13, 14] . In the revised model, local infection in the gastrointestinal or respiratory tract initially leads to low levels of circulating mycobacteria, which seed multiple tissues. Subsequently, a dynamic exchange of mycobacteria between blood and tissues increases concentration in both compartments. After prolonged and untreated MAC dissemination, tissue burden may become so heavy that sterilization is unlikely with currently available therapy. Therapy may have failed to sterilize blood and tissues in 7 of our 10 subjects because of high tissue burden, inadequate therapy, or selection of MAC for resistance to drugs. Regardless of the reason for treatment failure, a positive blood culture at autopsy usually indicates persisting MAC in tissues.
In 3 subjects, MAC was not cultured from blood or tissues at autopsy, but 2 had visible AFB in tissues. This apparent discrepancy might be due to nonviable MAC or to viable nonculturable organisms that might be culturable under other conditions. In a previous study conducted before the widespread availability of clarithromycin, we found that 13 (30%) of 44 AIDS patients with MAC bacteremia had no evidence of tissue involvement at autopsy [11] . In that study, the duration of MAC bacteremia was the most important determinant for the detection of MAC. In the current study, the 3 subjects with sterile tissues had MAC bacteremia for 5.2, 10.8, and 25.5 months, respectively, before death, and all had received clarithromycin for at least 3 months. MAC may have been cleared in these subjects, especially if blood and tissue burden was low at the time of diagnosis. In addition, relapse due to clarithromycin resistance might not have occurred because of a lower initial burden of organisms [18, 19] . Virulence factors of MAC isolates or host immunologic factors may also have played a role in determining tissue burden [20] . The proportion of patients without detectable AFB in tissues in our current and previous [11] studies and in another study [21] was similar. Thus, clarithromycin-containing regimens, which usually initially sterilize the blood, fail to sterilize the tissues of MAC in most patients.
In contrast to our finding of a correlation between levels of MAC in blood and tissue at autopsy, a recent study (DATRI 007) found no correlation between blood and bone marrow biopsy quantitative cultures [22, 23] in samples taken before and after initiation of treatment for symptomatic MAC bacteremia. While that study evaluated acute changes in the bone marrow during the early stages of therapy, our study evaluated the relationship between blood and tissues after chronic therapy. Methodologic differences may also explain the differences in results from the studies. The size of the sample, the site of the biopsy, as well as the processing techniques ofbone marrow aspirates differed from those of autopsy specimens. Thus, our data do not exclude the possibility that the bone marrow is a reservoir of mycobacteria that responds more slowly than the blood to acute treatment.
Of concern when drawing inferences from autopsy cultures is the possibility that events occurring immediately before or after death could produce artifactual changes in the levels of MAC in blood and tissues. First, transfer of MAC from tissue to blood agonally seems unlikely since the levels of MAC in autopsy blood samples are similar to those from living patients. Second, migration of MAC from reticuloendothelial tissues to cardiac blood after death is not feasible for a nonmotile bacteria. Last, mycobacteria have a slow doubling time (12 -18 h) at 37°C, thus minimizing the impact of growth ofmycobacteria after death [24] , especially at refrigerator temperatures during the brief delay between death and autopsy.
Previous studies of the histopathology of MAC in AIDS patients describe collections of foamy macrophages containing numerous AFB in the lymph nodes, spleen, liver, and gastrointestinal tract in the absence of an inflammatory response [7] [8] [9] [10] . The accumulation of MAC in organs rich in macrophages suggests that these macrophages effectively ingest MAC but cannot kill them [21, 25] . In addition to this general pattern, we observed organ-specific patterns of histopathology. In the spleen, FH formed cuffs around the arterioles between the marginal zone and the periarterial T cell-depleted lymphatic sheath of the white pulp [26] . Unlike previous reports [10, 27, 28] , involvement of the gastrointestinal system was focal and tended to remain confined to the lamina propria, where lymphatic capillaries and macrophagesare normally observed [29] . In most patients, the architecture ofthe mesenteric lymph nodes was completely effaced by FH containing numerous AFB. These patterns of gastrointestinal involvement support the concept that MAC colonizes then invades the lamina propria and the gastrointestinal lymphatics, allowing hematogenic dissemination to occur [13] .
Our findings have several practical clinical implications. First, the strong correlation between the numbers of organisms in blood and tissues suggests that quantitative blood cultures are useful for estimating the tissue burden in disseminated MAC. Second, although histology proved to be less sensitive than cultures, seeing AFB in tissues provides useful information. For example, the finding of abundant FH or AFB in biopsy specimens of the gut, lymph node, or liver of a patient at risk for MAC or tuberculosis. should prompt the clinician to draw AFB blood cultures and to anticipate a high burden of organisms in multiple tissues. However, because of the variability of tissue involvement, the absence of AFB on a biopsy specimen does not exclude MAC in other organs. The overall difficulty in sterilizing tissues supports the use of antimycobacterial prophylaxis and early treatment of MAC infection, when the burden of organisms is still low.
The reader should be aware of potential limitations to this study. First, our patients were all treated with clarithromycincontaining regimens for prolonged periods of time (9/1 0 for > 3 months), and 4 of 10 patients had been off treatment for various periods of time before death. In the remaining 6 subjects, compliance was unknown. Only 1 of the 10 patients died within 3 months of the initiation of therapy for MAC bacteremia. Thus, the correlation ofblood and tissue concentration of MAC observed in this study may not apply during the early stages of therapy.
Second, our patients may not be representative of other AIDS patients with MAC. We tried to address this potential bias by studying unselected, consecutively autopsied patients with MAC bacteremia.
Third, a sampling error may have underestimated histopathologic and microbiologic involvement by MAC in the gastrointestinal system, lung, and bone marrow because these organs had no grossly detectable lesions to direct sampling for histopathology or culture. Because gastrointestinal system involvement characteristically is focal and varies substantially within the same histologic slide [26, 30, 31] , we tried minimizing this error by examining multiple sections of the same patient.
Fourth, the decalcification procedure used in bone marrow autopsy specimens lasts at least 24 h, compared with 30 min in biopsies [32] , thereby potentially modifying the staining properties of mycobacteria in these specimens.
Fifth, inadequate disruption of macrophages by mechanical emulsification of solid tissues and the antimycobacterial effect of decontamination procedures for other· bacteria may have contributed to underestimation of tissue burden [15] .
Despite these caveats, we believe that this study quantifies the spectrum of organ involvement in disseminated MAC disease in AIDS patients treated with clarithromycin. Quantitative MAC blood cultures have been established as the reference standard of the acute impact of treatment [2, 4, 5, 18] . Our finding that quantitative MAC blood cultures are highly correlated with tissue burden further supports their use in treatment trials as a practical measure of the impact of chronic therapy on infected tissues.
